According to the “tau hypothesis”, the intracellular NFTs, mainly composed of abnormally phosphorylated and aggregated tau proteins, are considered as the principal effectors of neuronal loss and memory impairment in AD via the impairment of axonal transport. The gene discussed is MAPT; the disease is Alzheimer disease.